Manufacturer record
Cadila Pharmaceuticals Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
14 batches manufactured by Cadila Pharmaceuticals Limited (Gujarat) were declared Not of Standard Quality between January 2019 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
14 records linked to Cadila Pharmaceuticals Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ciprofloxacin Hydrochloride Tablets IP 500 mg | JKBD24080Mfg 2024-08 · Exp 2027-07 | The sample does not conform to IP Standards, It fails the test ' Dissolution' as per IP.Dissolution | DTL ThiruvananthapuramState lab | Nov 2025 |
| Ciprofloxacin Tablets IP 250 mg (Ciprodac 250) | CT24001Mfg 2024-02 · Exp 2027-01 | Dissolution" of CiprofloxacinDissolution | RDTL GuwahatiCDSCO lab | Apr 2025 |
| CIPRODAC 500 (Ciprofloxacin Tablets IP 500mg) | AN24014Mfg 2024-01 · Exp 2026-12 | The Sample does not conform to standard in respect of the test "Dissolution" performedDissolution | SDTL Agartala, TripuraState lab | Dec 2024 |
| Ciprofloxacin Tablets IP 500 mg (CIPRODAC 500) | JKBD24009Mfg 2024-01 · Exp 2026-12 | Dissolution of CiprofloxacinDissolution | RDTL GuwahatiCDSCO lab | Sep 2024 |
| RANITIDINE TABLETS IP 150mg (ACILOC 150) | LD21512Mfg 2021-10 · Exp 2024-03 | DescriptionDescription | RDTL GuwahatiState lab | Jun 2023 |
| Tinvista 300 (Tinidazole Tablets I.P. 300 mg) | JKGJ20001Mfg 2020-03 · Exp 2024-02 | DisintegrationDisintegration | CDL KolkataCDSCO lab | May 2023 |
| Ranitidine Tablets IP 150 mg (ACILOC 150) | LD22114Mfg 2022-02 · Exp 2024-07 | DescriptionDescription | RDTL GuwahatiState lab | Sep 2022 |
| ACILOC 150 (RANITIDINE TABLETS IP 150 mg) | LD21599Mfg 2021-12 · Exp 2024-05 | DescriptionDescription | RDTL GuwahatiState lab | Sep 2022 |
| CALNIF RETARD (Nifedipine Prolonged Release Tablets I.P. 20 mg) | JKEG21006Mfg 2021-07 · Exp 2024-06 | DissolutionDissolution | CDL KolkataCDSCO lab | May 2022 |
| TINVISTA 300 (Tinidazole Tablets IP 300 mg) | JKGJ20001Mfg 2020-03 · Exp 2024-02 | DisintegrationDisintegration | CDTL MumbaiCDSCO lab | Mar 2022 |
| Pantoprazole & Domperidone Tablets (PENTALOC-D) | JK19006Mfg 2019-08 · Exp 2022-07 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Sep 2021 |
| Ranitidine Injection IP 25mg/ml (ACILOC Injection) | RP20139Mfg 2020-06 · Exp 2023-05 | Particulate MatterParticulate matter | RDTL ChandigarhState lab | Nov 2020 |
| STOPVOM (Domperidone Tablets IP 10 mg) | JK17001Mfg 2017-01 · Exp 2019-12 | DissolutionDissolution | CDL KolkataCDSCO lab | Mar 2019 |
| Stopvom (Domperidone Tablets I.P. 10 mg) | JK17001Mfg 2017-01 · Exp 2019-12 | DissolutionDissolution | CDL KolkataCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.